The Office will be closed on Thursday November 28th and Friday November 29th in observance of theThanksgiving Holiday.

Advanced Pain and Neuromuscular Consultants of Brevard offers a comprehensive approach for the treatment chronic pain. 

Chronic pain can rule your life, interfering with your ability to work, sleep and enjoy your family and friends. When chronic pain disrupts your quality of life and does not improve with standard treatments, Advanced Pain and Neuromuscular Consultants of Brevard is here to help. 

There are many safe, proven effective treatments available that can eliminate or reduce chronic pain. The sooner you seek treatment, the sooner you can start enjoying life again.

We welcome you to come and learn more about our services. Please contact us if you have any additional questions.

Advanced Pain and Neuromuscular Consultants of Brevard specialists are Board-certified physicians are dedicated to the goal of helping people with chronic pain return to a normal, productive lifestyle.

Many of the patients referred to us have been through multiple other treatment options including interventional pain therapy and surgery.

Our physicians take into account all prior treatment modalities then, utilizing the best of current medical knowledge and technology, we will work with you to identify the source of your pain, then design what they feel will be your most effective pain relief program.


Thank you for visiting us!

Patient Safety Alert 4/5/13

 

Green Valley Drugs Announces Voluntary Nationwide Recall of All Lots of All Sterile Products
Compounded, Repackaged, and Distributed by Green Valley Drugs Due to Quality Control Concerns

Contact
Consumer:
702-564-2079
pharmacy@greenvalleymed.com
 

FOR IMMEDIATE RELEASE - April 5, 2013 - Henderson, NV, Green Valley Drugs is voluntarily recalling All Lots of All Sterile products compounded, repackaged, and distributed by the pharmacy due to lack of sterility assurance and concerns associated with the quality control processes. A full list of the recalled products is attached to this press release and can be accessed at greenvalleymed.com. The recall of sterile products is conducted based on observations of clean room personnel and certain aseptic techniques.

Green Valley has received no reports of injury or illness associated with the use of our sterile products. In addition, we have received no indications of endotoxins or sterility issues from independent outside testing laboratories associated with any of the products subject to this recall. Out of an abundance of caution and in the interest of our patients, Green Valley Drugs has decided to voluntarily proceed with this recall process.

In the event a sterile product is compromised patients are at risk for serious and possible life threatening infections.

Green Valley Drugs sterile products covered under this recall were distributed nationwide. Until further notice, health care providers should stop using all lots of sterile products and return them to the company.

Consumers or Health Care providers with questions regarding this recall may contact Green Valley Drugs by phone at 702-564-2079 or e-mail address at pharmacy@greenvalleymed.com; Monday through Friday between the hours of 9 am to 5 pm PST. Patients who have received any product distributed by Green Valley Drugs and have concerns should contact their healthcare provider.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

****Advanced Pain & Neuromuscular Consultants have NEVER USED PRODUCTS FROM THIS COMPANY.

 

Patient Safety Alert 4/16/13

Sterile Products Compounded, Repackaged, and Distributed by ApothéCure: Recall - Sterility Assurance Concerns

Posted By Dan Grams

ISSUE: ApothéCure, Inc. is voluntarily recalling all lots of sterile products compounded by the pharmacy that are not expired to the user level. The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes

BACKGROUND: The sterile products include all injectables with the clear message, "Independently tested for sterility,” noted on the vials as well as the ApothéCure name. ApothéCure’s sterile products covered under this recall were distributed nationwide and supplied to the offices of licensed medical professionals. To date, ApothéCure, Inc. has received no reports of injury or illness associated with the use of our sterile products. However, out of abundance of caution and in the interest of our patients, ApothéCure, Inc. has decided to voluntarily proceed with this recall process.

RECOMMENDATION: Consumers or Health Care providers with questions regarding this recall may contact ApothéCure, Inc. by phone at 800-969-6601 or 972-960-6601 from the hours of 9:30AM-6PM central time Monday-Friday or e-mail address at pharmacist@apothecure.com. Patients who have received any product distributed by ApothéCure and have concerns should contact their healthcare provider.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Read the MedWatch Safety Alert, including links to the Press Release HERE.

Source: U.S. Food and Drug Administration (FDA) (Accessed: 4/16/2013

****Advanced Pain & Neuromuscular Consultants have NEVER USED PRODUCTS FROM THIS COMPANY.

 

 

307 E. New Haven Avenue, Melbourne, FL 32901

307 E. New Haven Avenue
Melbourne, FL 32901

Office: 321.729.8223
Fax: 321.729.6252

Driving Directions

google-map0

8075 Spyglass Hill Road, Viera, FL 32940

8075 Spyglass Hill Road,
Viera, FL 32940

Office: 321.259.8993
Fax: 321.729.6252

Driving directions

google-map1

Latest News

FDA Panel Snubs Morphine-Oxycodone Combo

(MedPage Today) -- An FDA advisory committee has voted unanimously against approval of an oral combination of morphine and oxycodone (Moxduo) for acute pain. Read More

Hot Topics: Headache From Medication Overuse

(MedPage Today) -- How do you treat headache caused by medication overuse? Four experts described multipronged approaches that, in severe cases, may involve inpatient treatment to successfully detoxify patients. Read More

Online-Only Med School? The Anesthesiology News Report

(MedPage Today) -- A regular update on what?s new in anesthesiology from our friends at Anesthesiology News. Read More

Hot Topics: Opioids and Cannabis for Headache?

(MedPage Today) -- Is there a role for opioids or marijuana for treating migraine and other primary headache disorders? Three prominent specialists told us that opioids may have a limited place but the evidence weighs against cannabis for now. Read More

The WeekAhead: NKF, SGIM, and JAMA Does Neurology

(MedPage Today) -- This week MedPage Today staff head to Las Vegas for the National Kidney Foundation and San Diego for the Society of General Internal Medicine, while in Washington the FDA turns its attention to shocking therapies. Read More

Safe Epidurals, Hydrocodone Rescheduling: The Pain Medicine News Report

(MedPage Today) -- A regular update on what's new in surgery from our friends at Pain Medicine News. Read More

Morning Break: What Sebelius Achieved, The New ADHD

(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. Read More

On Doc Pay Release: 'You Cannot Call a Plumber for $57'

(MedPage Today) -- MedPage Today reached out to several physician leaders for their thoughts on the release of physician payment data from CMS, including Nancy Nielsen, MD, PhD, a past president of the AMA. Read More

Naloxone 'Stigma' a Barrier to Prescribing?

(MedPage Today) -- Although giving out naloxone to patients at high risk of overdose sounds like a good idea, researchers who work with the drug say the stigma surrounding its use may be a barrier to wider uptake among both patients and doctors. Read More

NSAIDs May Spark Afib

(MedPage Today) -- The risk of atrial fibrillation was higher among individuals ages 55 and older who were using nonsteroidal anti-inflammatory drugs (NSAIDs), a Dutch study showed. Read More

Morning Break: Balance Billing Ban, Harm in Work-Hour Limits?

(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. Read More

Morning Break: $$$ to Docs Report Coming

(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. Read More

Marijuana for MS. Now What?

(MedPage Today) -- Medical marijuana may have gained new legitimacy from the AAN's qualified endorsement for certain MS symptoms, but it's still a long way from conventional medicine. Read More

Morning Break: SGR 'Power-Play' Means Claim Processing Delay

(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. Read More

10 Questions: Laurie Glimcher, MD

(MedPage Today) -- "Frankly, I would never try to persuade someone to pursue a career in medicine." That was how Laurie H. Glimcher, MD, dean of Weill Cornell Medical College in New York City began her answer to one of the 10 questions MedPage Today is asking a wide range of healthcare providers. Read More

Muscle weakness seen in alcoholism linked to mitochondrial repair issues

Evidence found that chronic heavy alcohol use affects a gene involved in mitochondrial repair and muscle regeneration. Read More

Jump-starting natural resilience reverses stress susceptibility

Compensatory response shields mice from depression-like behaviors – NIH-funded study. Read More

Eavesdropping on brain cell chatter

NIH-funded researchers develop novel tools to learn how astrocytes listen in on neurons. Read More

Research consortium including NIH proposes diagnostic criteria for sarcopenia

Condition leads to disability in many older adults. Read More

Gene linked to excess male hormones in female infertility disorder

Discovery by NIH-supported researchers may lead to diagnostic test, treatment. Read More

Dr. Yvonne T. Maddox to serve as Acting Director of NIMHD

Her appointment follows the retirement of Dr. John Ruffin. Read More

Unexpected protein partnership has implications for cancer treatment

NIH scientists find unusual method that may alter tumor growth. Read More

GuLF STUDY gears up for second round of health exams

Research continues four years after the Deepwater Horizon oil spill. Read More

Too much protein may kill brain cells as Parkinson's progresses

NIH-funded study on key Parkinson's gene finds a possible new target for monitoring the disease. Read More

NIH funds influenza research and surveillance network

NIAID-supported centers integrate research to improve pandemic preparedness. Read More

Drug does not improve set of cardiovascular outcomes for diastolic heart failure

NIH-supported study finds drug does appear to reduce hospitalizations for diastolic heart failure Read More

Spinal stimulation helps four patients with paraplegia regain voluntary movement

Groundbreaking results bring new hope for those with spinal cord injury – NIH study. Read More

NIAAA Recognizes Alcohol Awareness Month 2014

April is Alcohol Awareness Month, a time to learn about the health and social problems caused by drinking too much. Read More

NIH-funded atlas details gene activity of the prenatal human brain, offers clues to psychiatric disorders

A comprehensive three-dimensional atlas of the developing human brain that incorporates gene activity along with anatomical reference atlases and neuroimaging data has released its first major report online today in Nature. Read More

Aspirin does not prevent pregnancy loss, NIH study finds

Increased live birth rate in subgroup of participants. Read More

Obesity primes the colon for cancer, according to NIH study

Obesity, rather than diet, causes changes in the colon that may lead to colorectal cancer, according to a study in mice by the National Institutes of Health. Read More

HIV-infected men at increased risk for heart disease, large study finds

NIH-supported research also identifies predictors of heart disease risk in this group. Read More

NIH celebrates grand opening of John Edward Porter Neuroscience Research Center

State of the art research facility on NIH campus will foster new collaborations among scientists studying the brain. Read More

Disorganized cortical patches suggest prenatal origin of autism

NIH-funded study shows disrupted cell layering process in the developing brain. Read More

NIHSeniorHealth.gov offers comprehensive information on end of life

Symptom management, practical concerns are focus of topic. Read More

Researchers discover underlying genetics, marker for stroke, cardiovascular disease

NIH-funded findings point to new potential strategies for disease prevention, treatment. Read More